Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug) is Buildings and Property in United States that focus on experimental anticoagulant drug business. They cover business area such as license, isis-FXIRx, Carlsbad, California.
-
Experimental Anticoagulant Drug
-
2855 Gazelle Court
Carlsbad, CA 92010
United States
Private
licenseisis-FXIRxCarlsbadCalifornia
* We use standard office opening hours in near Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug) is Buildings and Property business from United States that founded in - ( years old in ), Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug) business is focusing on Experimental Anticoagulant Drug.
Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug) headquarter office and corporate office address is located in 2855 Gazelle Court Carlsbad, CA 92010 United States.
Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug) was founded in United States.
In , Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug) is currently focus on experimental anticoagulant drug sector.
Above is snippet of Google Trends for "experimental anticoagulant drug" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
